COVID testing’s value shrinks as vaccines beat back virus
WASHINGTON — Federal health officials’ new, more relaxed recommendations on masks have all but eclipsed another major change in guidance from the government: Fully vaccinated Americans can largely skip...
View ArticleFDA approves much-debated Alzheimer’s drug panned by experts, first in nearly...
WASHINGTON — Government health officials on Monday approved the first new drug for Alzheimer’s disease in nearly 20 years, disregarding warnings from independent advisers that the much-debated...
View ArticleU.S. to spend $3.2B for antiviral pills for COVID-19, Dr. Anthony Fauci says
WASHINGTON — The United States is devoting $3.2 billion to advance development of antiviral pills for COVID-19 and other dangerous viruses that could turn into pandemics. Dr. Anthony Fauci, the...
View ArticleClik here to view.
Does new Alzheimer’s drug work? Answers may miss 2030 target.
WASHINGTON — When a controversial Alzheimer’s drug won U.S. approval, surprise over the decision quickly turned to shock at how long it might take to find out if it really works — nine years. Biogen...
View ArticleFDA adds warning of rare reaction risk to Johnson & Johnson COVID vaccine
WASHINGTON — U.S. regulators on Monday added a new warning to Johnson & Johnson’s COVID-19 vaccine about links to a rare and potentially dangerous neurological reaction, but said it’s not entirely...
View ArticleExtra COVID vaccine OK’d for those with weak immune systems
WASHINGTON — U.S. regulators on Thursday said transplant recipients and others with severely weakened immune systems can get an extra dose of the Pfizer or Moderna COVID-19 vaccines to better protect...
View ArticleMore protection: U.S. likely to authorize COVID-19 booster shots
WASHINGTON — After struggling for months to persuade Americans to get the COVID-19 vaccine, U.S. health officials could soon face a fresh challenge: talking vaccinated people into getting booster shots...
View ArticleU.S. health officials call for booster shots against COVID-19
WASHINGTON — U.S. health officials Wednesday announced plans to offer COVID-19 booster shots to all Americans to shore up their protection amid the surging delta variant and signs that the vaccines’...
View ArticleFDA gives full approval to Pfizer COVID-19 vaccine
WASHINGTON (AP) — The U.S. gave full approval to Pfizer’s COVID-19 vaccine on Monday, a milestone that may help lift public confidence in the shots as the nation battles the most contagious coronavirus...
View ArticleWhat does full approval of Pfizer’s COVID-19 vaccine mean?
What does full approval of Pfizer’s COVID-19 vaccine mean? It means Pfizer’s shot for people 16 and older has now undergone the same rigorous testing and regulatory review as dozens of other...
View ArticleFDA panel is first key test for Biden’s COVID-19 booster plan
WASHINGTON — The Biden administration’s embattled plan to dispense COVID-19 booster shots to most Americans faced its first major hurdle Friday as a government advisory panel met to decide whether to...
View ArticleClik here to view.
FDA backs Pfizer COVID-19 boosters for seniors, high-risk
The U.S. moved a step closer Wednesday to offering booster doses of Pfizer’s COVID-19 vaccine to senior citizens and others at high risk from the virus as the Food and Drug Administration signed off on...
View ArticleFDA endorses lower-dose Moderna COVID shot for booster
U.S. health advisers said Thursday that some Americans who received Moderna’s COVID-19 vaccine should get a half-dose booster to bolster protection against the virus. The panel of advisers to the Food...
View ArticleFDA panel endorses booster shot for J&J COVID-19 vaccine
WASHINGTON (AP) — U.S. health advisers endorsed a booster of Johnson & Johnson’s COVID-19 vaccine Friday, citing growing worry that Americans who got the single-dose shot aren’t as protected as...
View ArticlePfizer says COVID-19 vaccine more than 90% effective in kids
Kid-size doses of Pfizer’s COVID-19 vaccine appear safe and nearly 91% effective at preventing symptomatic infections in 5- to 11-year-olds, according to study details released Friday as the U.S....
View ArticleClik here to view.
FDA panel backs Pfizer’s low-dose COVID-19 vaccine for kids
WASHINGTON — The U.S. moved a step closer to expanding COVID-19 vaccinations for millions more children as a panel of government advisers on Tuesday endorsed kid-size doses of Pfizer’s shots for 5- to...
View ArticleClik here to view.
FDA paves way for Pfizer COVID-19 vaccinations in young kids
WASHINGTON — The Food and Drug Administration on Friday paved the way for children ages 5 to 11 to get Pfizer’s COVID-19 vaccine. The FDA cleared kid-size doses — just a third of the amount given to...
View ArticlePfizer says COVID-19 pill cut hospital, death risk by 90%
WASHINGTON — Pfizer Inc. said Friday that its experimental antiviral pill for COVID-19 cut rates of hospitalization and death by nearly 90% in high-risk adults, as the drugmaker joined the race for an...
View ArticleBiden picks ex-FDA chief Robert Califf to again lead agency
WASHINGTON — President Joe Biden on Friday chose Dr. Robert Califf, a former Food and Drug Administration commissioner, to again lead the powerful regulatory agency. Califf’s nomination comes after...
View ArticleU.S. opens COVID boosters to all adults, urges them for those 50 and older
WASHINGTON — The U.S. on Friday opened COVID-19 booster shots to all adults and took the extra step of urging people 50 and older to seek one, aiming to ward off a winter surge as coronavirus cases...
View Article
